Global Diabetes Diagnostics Market Report 2021: Market to Reach $42.4 Billion by 2026 - U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion

Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026

Amid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$26.5 Billion in the year 2020, is projected to reach a revised size of US$42.4 Billion by 2026, growing at a CAGR of 8.1% over the analysis period.

Test Strips, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$11.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lancets segment is readjusted to a revised 7.5% CAGR for the next 7-year period.

Blood glucose test strips are small disposable strips of plastic that enable people with diabetes to measure and monitor their blood sugar levels at home. Each test strip is a laminate of plastic and chemicals that provides a single-use diagnostic test for measuring blood sugar. Persistent growth in the blood glucose test strips market has been driven to a greater extent by an increase in number of diabetics, and also by technological innovations.

Blood sugar lancets play a vital role in the early detection of diabetes. The rising prevalence of diabetes, favorable reimbursement policies in developed countries, rising geriatric population, continuous technological advancements, and faster product approvals are some of the key factors spurring demand.

The U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion by 2026

The Diabetes Diagnostics market in the U.S. is estimated at US$10.8 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2026 trailing a CAGR of 9.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 7.1% respectively over the analysis period.

Within Europe, Germany is forecast to grow at approximately 8.1% CAGR. Growing prevalence of diabetes and other lifestyle and chronic diseases, ageing population, well-established healthcare infrastructure and wider access to care services, higher healthcare awareness among population, and consumer affluence strongly influence the demand for care and diagnostics services in developed countries.

Asia-Pacific represents a rapidly expanding market for diabetes diagnostics. Increased convenience, shift towards high-calorie energy-rich foods, and increasingly sedentary lifestyles are contributing to an alarming rise in incidence of diabetes in India and China making the countries the global hub for the disease with the highest number of diabetic adults.

Analog Glucose Monitors Segment to Reach $5.2 Billion by 2026

Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient`s finger or another place on the body. In the global Analog Glucose Monitors segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment.

These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.5 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$579.9 Million by the year 2026, while Latin America will expand at a 7.5% CAGR through the analysis period.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights

• World Market Trajectories

• Impact of COVID-19 and a Looming Global Recession

• Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management

• Diabetes: A Chronic Body Disorder

• An Introduction to Diabetes Diagnostics

• Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic

• Developed Regions Lead, Developing Economies to Spearhead Future Growth

• Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions

• Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices

• Diabetes Emerges as One of the Leading Causes of Mortality

• Competition

• Quality Products at Low Prices: Mantra for Success in the Marketplace

• SMBG Makers Turn to Mobile Devices to Woo Users on the Move

• World Brands

• Recent Market Activity

2. FOCUS ON SELECT PLAYERSSelect Competitors (Total 91 Featured)

• A.Menarini Diagnostics Ltd.

• Abbott Diabetes Care, Inc.

• Acon Laboratories, Inc.

• AgaMatrix, Inc.

• Apex Biotechnology Corporation

• ARKRAY, Inc.

• Ascensia Diabetes Care Holdings AG

• B. Braun Melsungen AG

• Becton, Dickinson and Company

• BIONIME Corporation

• Bio-Rad Laboratories, Inc.

• Danaher Corporation

• Beckman Coulter, Inc.

• HemoCue AB

• DexCom, Inc.

• Diazyme Laboratories Inc.

• EKF Diagnostics Holdings Plc

• LifeScan, Inc.

• Medtronic PLC

• Nova Biomedical Corporation

• OSANG Healthcare Co., Ltd.

• Roche Diabetes Care, Inc.

• Sanofi S.A.

• Sanwa Kagaku Kenkyusho Co, Ltd.

• Siemens Healthineers

• Sinocare, Inc.

• PTS Diagnostics

• Trividia Health, Inc.

• TaiDoc Technology Corporation

• Tandem Diabetes Care, Inc.

• Terumo Corporation

• Tosoh Bioscience, Inc.

• Trinity Biotech plc

• Ypsomed AG

3. MARKET TRENDS & DRIVERS

• High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion

• Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market

• Increasing Obesity Levels Underpins Market Growth

• Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market

• CGM Demand Benefits from the COVID-19 Pandemic

• CGM Market Breaks through Barriers to Witness Growing Adoption

• Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes

• Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market

• Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption

• Glycated Albumin: A Potential Threat to HbA1c

• Role of HbA1c Testing in Diabetes Diagnosis and Management

• HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants

• Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis

• Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth

• Blood Glucose Strips: Low Cost Advantage Augurs Drives Market

• Blood Sugar Lancets Market: Sustained Growth in Demand

• Self-Monitoring/Household Blood Glucose Sustains Market Growth

• Rising Smartphone Penetration Augurs Well for SMBG Market

• Barriers to Adoption of New Technology in BGM Products

• Accuracy Issues Plague Blood Glucose Meters Market

• Insulin Pens Rise in Popularity for Administering Insulin

• Smart Insulin Pens

• Increasing Role of Self-Injection Devices in Diabetes Management

• Prefilled Syringe Pen Injectors

• Human Factors Influence the Design of Self Injection Systems

• Pain Free Shots: A Growing R&D Domain

• Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market

• Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices

• Innovations & Product Advancements: Prime Focus Area for Vendors

• Focus on Development of Wearable Devices

• An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques

• Companies Develop Innovative Needle-Free Alternatives

• mHealth Solutions for Diabetes Diagnosis

• Non-invasive Wearable Glucose Testing Devices

• Innovations in Insulin Pumps

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES

• With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US

• Aging Demographics: A Factor Driving Diabetes Prevalence

• Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices

• Regulatory Guidance for Glucose Meter Companies

• Insulin Syringes Dominate the Insulin Delivery Devices Market

• Emerging Grey Market for Testing Strips

• Competition

• Companies Focus on Research for Better Diabetes Diagnostics

CANADA

• Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market

JAPAN

• Aging Population Drives Diabetes Diagnostics Market

CHINA

• Increasing Diabetes Incidence Drives Market Growth

• Lower Penetration Offers High Growth Potential

EUROPE

• Diabetes Diagnostics Market in Europe: A Promising Outlook

• Reimbursement Scenario

FRANCE

GERMANY

ITALY

UNITED KINGDOM

• Market Overview

• Diabetic Foot Ulcers in UK

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

• Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities

• Public and Private Sector Diabetes Care

AUSTRALIA

INDIA

• Expanding Diabetic Population Spurs Growth in the Indian Market

• Blood Glucose Monitoring Market: An Overview

• HbA1c Testing Continues to Gain Momentum

• Glucose Meters Rely on Imported Technology

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

• Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

• Total Companies Profiled: 91

For more information about this report visit https://www.researchandmarkets.com/r/f5n10m

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900